Partnering is central to Vivesto’s strategy to build a sustainable oncology development portfolio. Vivesto is actively seeking opportunities to acquire and license novel product opportunities in cancer where there is significant medical need. Vivesto is seeking to acquire or license global development rights to oncology programs in late stage pre-clinical or early clinical development stage.
